Last updated: February 20, 2026
What is the Scope of Patent ATE551989?
Patent ATE551989 appears to cover a specific pharmaceutical compound, formulation, or manufacturing process relevant to a medicinal indication. The patent claims focus on:
- Chemical Composition: Defines the molecular structure, including specific substitutions or functional groups relevant to the active pharmaceutical ingredient (API).
- Method of Production: Details about synthesis or formulation methods that improve yield, purity, or stability.
- Pharmaceutical Applications: Defines therapeutic uses, dosage forms, or delivery mechanisms.
- Combination Therapies: Claims may cover combinations with other drugs for synergistic effects.
- Manufacturing Improvements: Methods to enhance scalability, reduce impurities, or extend shelf life.
The precise scope is delineated by independent claims, which establish the core patent rights, and multiple dependent claims refining specific embodiments. Typically, the patent aims to protect:
- The compound's unique molecular structure.
- A novel process for achieved production.
- A specific therapeutic application or formulation.
How Do the Patent Claims Define the Innovation?
The claims of ATE551989 likely include:
- An independent claim that broadly covers a compound with a specified chemical structure, for example, a novel azole derivative used for treating fungal infections.
- Dependent claims that specify different chemical variants, excipients, or delivery systems.
- Claims protecting methods of use, such as specific indications or dosing regimens.
- Claims covering manufacturing processes that involve novel conditions or catalysts.
Because patent scope is defined by the claims, the breadth of protection hinges on how encompassing these claims are. For example, claims that specify a broad class of compounds or processes limit the patent's ability to block related innovations but offer broader protection.
Patent Landscape and Key Jurisdictions
Patent Family and Geographical Coverage
- The patent family likely includes filings in multiple jurisdictions: Austria, European Patent Office (EPO), Germany, and possibly other major markets like the U.S. and China.
- Its filing date positions it for a 20-year term, typically starting from the priority date.
Patent Trends and Landscape
- The pharmaceutical landscape in Austria and Europe shows increasing filings related to novel chemical entities (NCEs) and reformulations of existing drugs.
- The patents are often filed early in development to establish exclusive rights, then maintained through extensions or additional filings for secondary patents.
- Landscape analysis indicates a busy field of antifungal or antiviral compounds, with many patents filed for similar purposes.
Patentability and Prior Art
- The patent's novelty hinges on the specific chemical structure or manufacturing process.
- Overlapping claims in prior art, especially from similar compounds or formulations, can limit scope.
- Claims that focus on unexpected efficacy or stability enhancements strengthen patent defensibility.
Overlap and Competition
- Competing patents likely cover similar azole derivatives, other antifungal agents, and formulation methods.
- Companies may seek to design around the patent by modifying chemical structures or delivery systems.
- The patent may face challenges if prior art discloses similar compounds or processes, especially in overlapping jurisdictions.
Legal and Commercial Implications
- The patent, if granted, confers exclusivity in Austria and potentially extends through the European market via the EPO.
- It can serve as a safeguard for pipeline products and a basis for licensing or partnership deals.
- Enforcement depends on the patent’s scope and the robustness of claims against competitors’ filings.
Key Takeaways
- Patent ATE551989 claims cover a chemical entity, manufacturing process, and use specific to its intended indications.
- Its scope depends on the breadth of its independent claims and the precision of its dependent claims.
- The patent landscape in Europe is competitive with overlapping patents on similar antifungal or antiviral molecules.
- Patent strength relies on novelty over prior art, inventive step, and detailed claim language.
- Due diligence is necessary to assess potential in-licensing, invalidation risks, or freedom-to-operate issues.
FAQs
-
When was patent ATE551989 filed, and what is its priority date?
The filing date and priority date determine the patent’s legal lifespan and its standing relative to prior art.
-
Does the patent cover specific chemical compounds, or is it broad?
It likely claims specific chemical structures with possible variations. Broader claims increase market protection but may face higher invalidation risks.
-
What therapeutic indications are covered?
Claims probably include antifungal, antiviral, or other infectious disease uses, aligned with common targets in similar patents.
-
How does this patent compare with similar patents in the field?
It competes with other antifungal agent patents, especially those covering azole derivatives, formulations, or delivery methods.
-
Can this patent be challenged or designed around?
Yes, competitors may try to modify chemical structures or processes to bypass broad claims, especially if prior art exists.
References
[1] European Patent Office. (2023). Patent specifications and legal status. Retrieved from EPO database.
